Bcr Abl In Chronic Myeloid Leukemia - Epidemiology

Relevant Publications

New Inhibitors of Bcr-Abl Based on 2,6,9-Trisubstituted Purine Scaffold Elicit Cytotoxicity in Chronic Myeloid Leukemia-Derived Cell Lines Sensitive and Resistant to TKIs.

Issue Release: 2024

Combination of an aurora kinase inhibitor and the ABL tyrosine kinase inhibitor asciminib against ABL inhibitor-resistant CML cells.

Issue Release: 2024

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach.

Issue Release: 2024

Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models.

Issue Release: 2024

Pharmacokinetics of Dasatinib in Rats: a Potential Food-Drug Interaction with Naringenin.

Issue Release: 2024

Gene expression profiling on CML patients with Philadelphia translocation.

Issue Release: 2024

Targeted disruption of the fusion gene by Cas9/dual-sgRNA inhibits proliferation and induces apoptosis in chronic myeloid leukemia cells.

Issue Release: 2024

Computer-aided drug discovery of c-Abl kinase inhibitors from plant compounds against chronic myeloid leukemia.

Issue Release: 2024

A novel fluorescent probe based imprinted polymer-coated magnetite for the detection of imatinib leukemia anti-cancer drug traces in human plasma samples.

Issue Release: 2024

Chronic myeloid leukemia in an ulcerative colitis patient receiving azathioprine: A case report.

Issue Release: 2024

Structure-guided drug design targeting Abl kinase: how structure and regulation can assist in designing new drugs.

Issue Release: 2024

Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.

Issue Release: 2024

Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK.

Issue Release: 2024

Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy.

Issue Release: 2024

A Case of Hepatocellular Carcinoma after Treatment for Chronic Myeloid Leukemia in a Patient without Liver Disease.

Issue Release: 2024

Comparative analysis of BCR::ABL1 p210 mRNA transcript quantification and ratio to ABL1 control gene converted to the International Scale by chip digital PCR and droplet digital PCR for monitoring patients with chronic myeloid leukemia.

Issue Release: 2024

Retraction: Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.

Issue Release: 2024

Bilateral Sudden Irreversible Hearing Loss in a Case of Chronic Myeloid Leukaemia: A Case Report.

Issue Release: 2024

A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia.

Issue Release: 2024

Mechanisms underlying therapeutic resistance of tyrosine kinase inhibitors in chronic myeloid leukemia.

Issue Release: 2024

Why Are Headlines Important in Epidemiology?

How Can We Promote Data Sharing in Epidemiology?

What is Iterative Evaluation in Epidemiology?

What are the Assumptions in Mediation Analysis?

What Are the Best Practices for Conducting Security Audits?

Why are Clear Objectives Important?

Why Are Safety Devices Important?

What are Syndromic Surveillance Systems?

How Does Epidemiology Benefit Public Health Research?

What Information Is Typically Found on Epidemiology Company Pages?

Bcr Abl In Chronic Myeloid Leukemia - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics